Le Lézard
Classified in: Covid-19 virus

Global $12.18 Billion CBD Gummies Market Forecast to 2028 - ResearchAndMarkets.com


The "CBD Gummies Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Category and Distribution Channel" report has been added to ResearchAndMarkets.com's offering.

The CBD gummies market was valued at US$ 2,133.48 million in 2021 and is projected to reach US$ 12,182.21 million by 2028. It is expected to grow at a CAGR of 28.3% from 2021 to 2028.

CBD or cannabidiol is an active component in cannabis (marijuana). It is gaining huge traction due to its medicinal and healing effects. According to the World Health Organization (WHO), CBD demonstrates no effects suggestive of any misuse or dependency potential in people.

Based on distribution channel, the CBD gummies market is segmented into specialty stores, online retail, and others. The specialty stores segment accounted for the largest market share in 2020. The online retail segment is projected to grow at the fastest CAGR over the forecast period.

E-commerce platforms have registered significant growth as they provide lucrative services, such as home delivery, discounts, offers, cashback, to the customers. Moreover, customers can choose among a wide range of products by comparing different alternatives available.

A variety of CBD gummies brands are available on e-commerce platforms like Amazon.com. Thus, the high availability of CBD gummies brands at affordable prices is one of the key factors driving the online retail segment.

Based on region, the CBD gummies market is segmented into North America, Europe, and the Rest of the World. In 2020, North America held the largest share of the global CBD gummies market, whereas Europe is projected to register the fastest growth over the forecast period. Europe has a significant concentration of cannabis consumers.

Recently, the European Union has legalized CBD; hence, manufacturers of CBD gummies have a strong growth potential across European nations such as France, Germany, the UK, and Poland. CBD gummies consumption is proliferating rapidly across markets in Europe as manufacturers are focusing on lowering the THC content and using clean-label and organic ingredients.

Moreover, CBD regulations are getting softer as authorities in EU Member States now regard CBD as a novel product for food, beverages, and food supplements. These factors are projected to support the growth of the CBD gummies market across Europe over the coming years.

The leading players in the CBD gummies market include Aurora Cannabis, Inc.; Canopy Growth USA, LLC; CBD American Shaman; CV Sciences, Inc.; Diamond CBD; CBDfx; Sunday Scaries; Medix CBD; Reliva CBD; and Fab CBD.

Reasons to Buy

Key Market Dynamics

Market Drivers

Market Restraints

Market Opportunities

Future Trends

Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/y34yta


These press releases may also interest you

at 12:27
This year marks the 14th anniversary of the enactment of the Affordable Care Act (ACA). Its passage was the most significant advancement of health policy since the establishment of Medicare and Medicaid in the 1960s and made healthcare accessible and...

at 12:15
Linc Housing announced that construction is underway on North Harbor...

at 11:30
The "Global Antibody Therapeutic Market: Focus on Format, Disease Area, Route of Administration, End Users, Region, and Competitive Landscape - Analysis and Forecast, 2024-2033" report has been added to  ResearchAndMarkets.com's offering. The global...

at 11:15
The "Europe Power Supply Equipment Market for Water Electrolysis: Focus on Application, Equipment Type, and Country - Analysis and Forecast, 2023-2032" report has been added to ResearchAndMarkets.com's offering. The Europe power supply equipment...

at 11:05
iLearningEngines Inc. ("iLearningEngines" or "the Company"), a leader in AI-powered learning automation and information intelligence for corporate and educational use, today announced that Michael Moe and Ian Davis will join the board of directors...

at 11:00
Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura,...



News published on and distributed by: